Latest news and stories about medical research in health in Portugal for expats and residents.
More recently, scientists studying biological clocks have discovered that the immune system appears to be extremely sensitive to time.
Statements from the protagonists of the 11th edition of the Gilead Génese Programme, an initiative for which Expresso has partnered as a media outlet.
Discovery identifies a three-step pathway for memory loss
Swedish researchers analysed nearly 15,000 people and discovered that certain antibiotics leave lasting traces in the gut — with possible links to type 2 diabetes.
A study from the University of California concluded that women show different responses than men regarding a protein linked to Alzheimer's disease, p-tau217, paving the way for a diagnosis several decades early.
A British study investigates a novel medication aimed at addressing the underlying causes of Dravet syndrome, a severe form of epilepsy, rather than merely alleviating symptoms. This research is particularly significant for over a hundred patients in Portugal who are affected by this condition.
Bladder cancer presents significant challenges from diagnosis to treatment, but recent advancements in prognosis and ongoing scientific research indicate promising developments in the field.
Home News Portuguese scientist investigating male infertility Portuguese scientist investigating male infertility The University of Aveiro is developing a new molecular method to diagnose male infertility and optimise the choice of reproductive therapies for couples, an academic source revealed.
Researchers used the technique of vat photopolymerization to produce custom-made parts for each patient.
After more than 200 days without further treatment, the animals remained disease-free and showed no signs of toxicity associated with the therapy.
NOVA Medical School has become part of the inaugural UNESCO Chair focused on Health Education and 'bem‑viver' — a holistic concept of living well — aiming to promote education, research and policies that enhance health and quality of life.
A study published today in the journal Psychological Medicine by the University of Cambridge, UK, indicates that menopause is associated with loss of grey matter and with brain changes similar to those observed in Alzheimer's disease.
Study indicates that menopause is associated with loss of grey matter, which is vital for mental functions, memory, emotions and movement.
Menopause may be linked to cognitive changes similar to those seen in Alzheimer’s disease, caused by a reduction in grey matter volume in brain regions associated with emotion and memory, according to a new study from the University of Cambridge.
Scientists analysed the genetic data of nearly 140,000 embryos from in vitro fertilisation (IVF) and found robust links between specific variations in the mother’s DNA and her risk of miscarriage.
The posture and position of someone performing resuscitation on a victim in cardiorespiratory arrest can affect the effectiveness of the manoeuvres. This is the conclusion of an international study led by the Faculty of Medicine of the University of Porto.
It is an innovative method that, in an animal model, shows survival rates of 80% to 100% for ovarian cancer. Clinical trials will take time, but the approach could revolutionise future therapies.
Results from a five-year study were presented on Tuesday by pharmaceutical companies Moderna and Merck.
Findings suggest a possible link between activity in specific brain pathways and the immune system, which could help identify targets associated with the placebo effect in humans.
Early symptoms can go unnoticed by people who have difficulty with colour vision. People with bladder cancer who are colour-blind had a 52% higher risk of dying after diagnosis, a study says.
People with bladder cancer who are colour-blind were 52% more likely to die within 20 years of diagnosis.
Two Cape Verdean researchers aim to strengthen the diagnosis of blood cancer and the “rational use” of antibiotics in Cape Verde through projects funded by the Calouste Gulbenkian Foundation, with the goal of improving healthcare in the country.
It is known that everyone who develops multiple sclerosis has previously had infectious mononucleosis, or the “kissing disease”.
A new study from the Karolinska Institute strengthens evidence that Epstein–Barr virus (EBV), the common cause of glandular fever, can trigger an immune response that damages the brain and may contribute to the development of multiple sclerosis (MS). The research supports the hypothesis that EBV infection is a key environmental driver of MS, a chronic inflammatory neurological disease affecting nearly three million people worldwide, in which the immune system attacks the central nervous system.